Cargando…

New concepts for CML clonality

Detalles Bibliográficos
Autores principales:	Khorashad, Jamshid S., Deininger, Michael W., O'Hare, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702202/ https://www.ncbi.nlm.nih.gov/pubmed/23448894

Ejemplares similares

Ongoing Clonal Evolution in Chronic Myelomonocytic Leukemia on Hypomethylating Agents: A Computational Perspective
por: Than, Hein, et al.
Publicado: (2018)

Kinase Inhibitor Therapy in CML: It's What's Inside That Counts
por: Eide, Christopher A., et al.
Publicado: (2013)

Advances in the treatment of chronic myeloid leukemia
por: Eiring, Anna M, et al.
Publicado: (2011)

Cobll1: A new player in CML
por: Kim, Hongtae, et al.
Publicado: (2017)

Eradication of CML stem cells
por: Carter, Bing Z., et al.
Publicado: (2016)

Chronic Myelogenous Leukemia (CML) in the elderly
por: Balducci, Lodovico, et al.
Publicado: (2014)

RAPID CONVERSION OF CHRONIC MYELOID LEUKEMIA TO CHRONIC MYELOMONOCYTIC LEUKEMIA IN A PATIENT ON IMATINIB THERAPY
por: Khorashad, Jamshid S., et al.
Publicado: (2016)

Cytogenetic alterations in CML: not all created equal
por: Gong, Zimu, et al.
Publicado: (2018)

MEK/ERK addiction in CNL/aCML
por: Kesarwani, Meenu, et al.
Publicado: (2017)

Molecular response prediction in CML: novel ideas?
por: Wolf, Dominik, et al.
Publicado: (2017)

The expanding CML treatment landscape: an introspective commentary
por: Lipton, Jeffrey H.
Publicado: (2023)

Clonal evolution in a patient with CML detected by FISH precedes imatinib treatment failure
por: Enriquez, Virginia, et al.
Publicado: (2007)

Radotinib is an Effective Inhibitor of Native and Kinase Domain-Mutant BCR-ABL1
por: Zabriskie, Matthew S., et al.
Publicado: (2015)

Current CML guidelines overemphasize second generation TKIs: revisiting the paradigm
por: Walia, Anushka, et al.
Publicado: (2023)

The New ELN Recommendations for Treating CML
por: Hehlmann, Rüdiger
Publicado: (2020)

Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches
por: Valent, Peter
Publicado: (2007)

Adding a new facet to STAT5 in CML: Multitasking for leukemic cells
por: Warsch, Wolfgang, et al.
Publicado: (2013)

Evolution of clonal hematopoiesis
por: van Zeventer, Isabelle A., et al.
Publicado: (2023)

NGS in CML - New standard diagnostic procedure?
por: Branford, Susan, et al.
Publicado: (2019)

β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia
por: Eiring, Anna M., et al.
Publicado: (2015)

A BCR-ABL Mutant Lacking Direct Binding Sites for the GRB2, CBL and CRKL Adapter Proteins Fails to Induce Leukemia in Mice
por: Johnson, Kara J., et al.
Publicado: (2009)

Cytogenetic study in CML
por: Subramanian, P.G.
Publicado: (2012)

CML: Evolution and design
por: Murray-Rust, Peter, et al.
Publicado: (2011)

Treatment-Free Remission: the New Goal in CML Therapy
por: Atallah, Ehab, et al.
Publicado: (2021)

Chipping in on clonal hematopoiesis
por: Gillis, Nancy K., et al.
Publicado: (2017)

COVID-19 in Patients (pts) with Chronic Myeloid Leukemia (CML): Results from the International CML Foundation (iCMLf) CML and COVID-19 (CANDID) Study
por: Rea, Delphine, et al.
Publicado: (2020)

New Conceptions in Malaria
Publicado: (1926)

New Conceptions in Amœbiasis
Publicado: (1926)

LINE-1 and Alu retrotransposition exhibit clonal variation
por: Streva, Vincent A, et al.
Publicado: (2013)

Clonal Extinction Drives Tumorigenesis
por: Amaro, Adriana, et al.
Publicado: (2023)

Current treatment approaches in CML
por: Castagnetti, Fausto, et al.
Publicado: (2019)

New dosing schedules of dasatinib for CML and adverse event management
por: Wong, Siu-Fun
Publicado: (2009)

Genomic Abnormalities as Biomarkers and Therapeutic Targets in Acute Myeloid Leukemia
por: Ribeiro, Sara, et al.
Publicado: (2021)

TET2 mutations and clonal dynamics
por: Kishtagari, Ashwin, et al.
Publicado: (2019)

Expanding approaches to detect clonal hematopoiesis
por: Khan, M.A. Wasay, et al.
Publicado: (2021)

A Coiled-Coil Mimetic Intercepts BCR-ABL1 Dimerization in Native and Kinase-Mutant Chronic Myeloid Leukemia
por: Woessner, David W., et al.
Publicado: (2015)

The Ca(2+) sensor proteins CML37 and CML42 antagonistically regulate plant stress responses by altering phytohormone signals
por: Heyer, Monika, et al.
Publicado: (2021)

CMLLite: a design philosophy for CML
por: Townsend, Joe A, et al.
Publicado: (2011)

Body composition in heart failure and the impact of cardiac resynchronisation therapy: a proof-of-concept study
por: McAloon, Christopher J, et al.
Publicado: (2020)

Similar expression profiles in CD34(+) cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinib
por: Patel, Ami B., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6i2f1i4rbuvnkdq4h7eulqier1